Advanced IVF Research To Be Launched

22.06.2012

Study combines two cutting-edge technologies to further understanding of embryo development.

A company at the forefront of reproductive health innovation, today announced the commencement of a groundbreaking research study with Reproductive Medicine Associates of New Jersey (RMANJ), an internationally-renowned fertility clinic that has pioneered and successfully implemented cutting-edge clinical advancements to more accurately detect healthy embryos for patients undergoing in vitro fertilization (IVF).

The company is committed to funding and conducting rigorous scientific research to continually improve outcomes for IVF patients," said the president and chief executive officer. "We are pleased to partner with RMANJ and believe this study may expand our understanding of embryo development dramatically, potentially leading to further improvement in our ability to detect healthy embryos during assisted reproduction procedures."

Patients enrolled in the study will be those who have determined, after consultation with their physician, to undergo pre-implantation genetic diagnosis using Comprehensive Chromosome Screening (CCS), a new rapid-method 24-chromosome screening technique first implemented at RMANJ. During the study, all embryos will be monitored using the Eeva™ (Early Embryo Viability Assessment) Test, a non-invasive test developed by Auxogyn to record and quantitatively analyze embryo development against scientifically- and clinically-validated cell-division time periods.

"Our objectives at RMANJ are two-fold: to increase the healthy live birth rate for those undergoing assisted reproductive procedures, and to decrease the multiple embryo transfer rate, thereby reducing multiple pregnancies," commented the founding partner of RMANJ. "Through this collaborative research study, we will explore new, previously unidentified factors that cause one euploid embryo to implant where another seemingly healthy embryo does not. These discoveries could directly impact clinical practice in the future, moving us closer to the ultimate goal of the IVF field – one embryo, one healthy baby."

prnewswire.com